Standard Biotools is trading 5.36% down now at $0.67, with no clear company-specific announcement or credible news catalyst identified for August 17, 2026.
- Shares declined from $0.71 on August 14 and $0.75 on August 13.
- Major indexes are down less than 0.5%; broader market sentiment does not clearly explain the decline.
- Recent second-quarter results and merger-related updates remain prior context, not a confirmed catalyst today.